These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Fetal valproate syndrome: is there a recognisable phenotype? Winter RM; Donnai D; Burn J; Tucker SM J Med Genet; 1987 Nov; 24(11):692-5. PubMed ID: 3123693 [TBL] [Abstract][Full Text] [Related]
8. Valproic acid embryopathy: report of two siblings with further expansion of the phenotypic abnormalities and a review of the literature. Kozma C Am J Med Genet; 2001 Jan; 98(2):168-75. PubMed ID: 11223853 [TBL] [Abstract][Full Text] [Related]
9. Congenital malformations associated with maternal use of valproic acid. Huot C; Gauthier M; Lebel M; Larbrisseau A Can J Neurol Sci; 1987 Aug; 14(3):290-3. PubMed ID: 3117346 [TBL] [Abstract][Full Text] [Related]
10. [Combination of hydantoins and valproate. Evidence of its teratogenic effect in 4 consecutive gestations]. Durá T; Moya M; Muñoz M; Juste M; Castaño C An Esp Pediatr; 1986 Dec; 25(6):457-61. PubMed ID: 3103508 [TBL] [Abstract][Full Text] [Related]
11. [The first case of a child born with fetal valproic acid syndrome in Hungary]. Robinek F; Czeizel E Orv Hetil; 1989 Jan; 130(5):267. PubMed ID: 2492655 [No Abstract] [Full Text] [Related]
12. Holoprosencephaly and the teratogenicity of anticonvulsants. Holmes LB; Harvey EA Teratology; 1994 Feb; 49(2):82. PubMed ID: 8016748 [No Abstract] [Full Text] [Related]
13. Middle and inner ear malformations in two siblings exposed to valproic acid during pregnancy: a case report. Van Houtte E; Casselman J; Janssens S; De Kegel A; Maes L; Dhooge I Int J Pediatr Otorhinolaryngol; 2014 Nov; 78(11):2007-10. PubMed ID: 25216807 [TBL] [Abstract][Full Text] [Related]
14. A child with a DIC (15p; 22p) centric fusion and fetal Valproate syndrome. Sharief N; Adams T; Butler L; Gnanaratnam J Indian Pediatr; 1999 May; 36(5):507-10. PubMed ID: 10728044 [No Abstract] [Full Text] [Related]
15. Radial ray aplasia in utero: a prenatal finding associated with valproic acid exposure. Ylagan LR; Budorick NE J Ultrasound Med; 1994 May; 13(5):408-11. PubMed ID: 8015052 [No Abstract] [Full Text] [Related]
16. A case of fetal valproate syndrome with new features expanding the phenotype. Al-Mendalawi MD; Seidahmed MZ Saudi Med J; 2009 Jul; 30(7):977; author reply 977-8. PubMed ID: 19618023 [No Abstract] [Full Text] [Related]
17. Fetal valproate embryopathy in twins: genetic modification of the response to a teratogen. Hockey A; Bower C; Goldblatt J; Knowles S Birth Defects Orig Artic Ser; 1996; 30(1):401-5. PubMed ID: 9125345 [No Abstract] [Full Text] [Related]
18. [Severe bone malformations in fetal valproic acid disease]. Lorenzo Sanz G; Serna Saugar C; Quintana Castilla A; Lozano Giménez C; Aparicio Meix JM An Esp Pediatr; 1993 Jul; 39(1):19-21. PubMed ID: 8363144 [TBL] [Abstract][Full Text] [Related]
19. Omphalocele in a newborn baby exposed to sodium valproate in utero. Boussemart T; Bonneau D; Levard G; Berthier M; Oriot D Eur J Pediatr; 1995 Mar; 154(3):220-1. PubMed ID: 7758521 [TBL] [Abstract][Full Text] [Related]
20. Dangers of valproate in pregnancy. Wieck A; Jones S BMJ; 2018 Apr; 361():k1609. PubMed ID: 29669728 [No Abstract] [Full Text] [Related] [Next] [New Search]